Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.

Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats. PLoS One (2014) 0.78

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA (2000) 20.35

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet (1988) 10.82

Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol (2000) 1.28

Endoscopic removal of a toothbrush. Gastrointest Endosc (1983) 1.25

Comparative study of secretin and Lundh tests. Am J Dig Dis (1975) 1.08

The liver in secondary syphilis. South Med J (1982) 1.03

Upper gastrointestinal endoscopy in normal asymptomatic volunteers. Gastrointest Endosc (1986) 1.02

Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo. J Rheumatol (2000) 0.94

Prevalence and cost of hospitalization for gastrointestinal complications related to peptic ulcers with bleeding or perforation: comparison of two national databases. Am J Manag Care (1998) 0.87

Intestinal obstruction due to acute pancreatitis. Case report and review of literature. Am J Dig Dis (1974) 0.85

Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1. Dig Dis Sci (1985) 0.85

Prostaglandins: an overview of the worldwide clinical experience. J Assoc Acad Minor Phys (1991) 0.84

Comparative cytoprotective effects against alcohol insult. Misoprostol versus cimetidine. Dig Dis Sci (1986) 0.84

Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update. J Physiol Pharmacol (1995) 0.80

[Raised trypsin concentration in duodenal secretion after a test meal (Lundh test) (author's transl)]. Dtsch Med Wochenschr (1975) 0.78

Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. Int J Clin Pharmacol Res (1989) 0.77

Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage. A double-blind endoscopic study in human subjects. Gastrointest Endosc (1986) 0.76

Immunoreactive somatostatin in human pancreatic secretion. J Clin Endocrinol Metab (1981) 0.76

HIV-1 gp41 antigen demonstration in esophageal ulcers with acquired immunodeficiency syndrome. J Clin Gastroenterol (1991) 0.75

Selective COX-2 inhibitors and gastrointestinal mucosal injury: pharmacological and therapeutic considerations. J Assoc Acad Minor Phys (2000) 0.75

Chylothorax following esophagoscopy, unusual complication of endoscopy. Gastrointest Endosc (1974) 0.75

The endoscopic appearance of anaphylactoid purpura. Gastrointest Endosc (1973) 0.75